Sakuranetin as a Potential Regulator of Blood Pressure in Spontaneously Hypertensive Rats by Promoting Vasorelaxation through Calcium Channel Blockade

Natural compounds, known for diverse pharmacological properties, have attracted attention as potential sources for hypertension treatment. Previous studies have revealed the hypotensive effect and vascular relaxation of prunetin, a natural compound derived from <i>Prunus yedoensis</i>. H...

Full description

Bibliographic Details
Main Authors: Sujin Shin, Junkyu Park, Ho-Young Choi, Youngmin Bu, Kyungjin Lee
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/12/2/346
_version_ 1797298840220467200
author Sujin Shin
Junkyu Park
Ho-Young Choi
Youngmin Bu
Kyungjin Lee
author_facet Sujin Shin
Junkyu Park
Ho-Young Choi
Youngmin Bu
Kyungjin Lee
author_sort Sujin Shin
collection DOAJ
description Natural compounds, known for diverse pharmacological properties, have attracted attention as potential sources for hypertension treatment. Previous studies have revealed the hypotensive effect and vascular relaxation of prunetin, a natural compound derived from <i>Prunus yedoensis</i>. However, the potential blood pressure-lowering and vasorelaxant effects of sakuranetin, another representative compound found in plants belonging to the genus <i>Prunus</i>, have remained unexplored. We aimed to fill this gap by investigating the hypotensive and vasorelaxant effects of sakuranetin in rats. Results indicated that sakuranetin, particularly in the sakuranetin 20 mg/kg group, led to significant reductions in systolic blood pressure (SBP) and diastolic blood pressure (DBP) by −14.53 ± 5.64% and −19.83 ± 6.56% at 4 h after administration. In the sakuranetin 50 mg/kg group, the SBP and DBP decreased by −13.27 ± 6.86% and −16.62 ± 10.01% at 2 h and by −21.61 ± 4.49% and −30.45 ± 5.21% at 4 h after administration. In addition, we identified the vasorelaxant effects of sakuranetin, attributing its mechanisms to the inhibition of calcium influx and the modulation of angiotensin II. Considering its hypotensive and vasorelaxant effects, sakuranetin could potentially serve as an antihypertensive agent. However, further research is required to evaluate the safety and long-term efficacy.
first_indexed 2024-03-07T22:41:53Z
format Article
id doaj.art-a3476314a7f849bc821c106a7fdcf235
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-07T22:41:53Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-a3476314a7f849bc821c106a7fdcf2352024-02-23T15:08:33ZengMDPI AGBiomedicines2227-90592024-02-0112234610.3390/biomedicines12020346Sakuranetin as a Potential Regulator of Blood Pressure in Spontaneously Hypertensive Rats by Promoting Vasorelaxation through Calcium Channel BlockadeSujin Shin0Junkyu Park1Ho-Young Choi2Youngmin Bu3Kyungjin Lee4Department of Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Republic of KoreaDepartment of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Republic of KoreaDepartment of Herbal Pharmacology, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of KoreaDepartment of Herbal Pharmacology, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of KoreaDepartment of Herbal Pharmacology, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of KoreaNatural compounds, known for diverse pharmacological properties, have attracted attention as potential sources for hypertension treatment. Previous studies have revealed the hypotensive effect and vascular relaxation of prunetin, a natural compound derived from <i>Prunus yedoensis</i>. However, the potential blood pressure-lowering and vasorelaxant effects of sakuranetin, another representative compound found in plants belonging to the genus <i>Prunus</i>, have remained unexplored. We aimed to fill this gap by investigating the hypotensive and vasorelaxant effects of sakuranetin in rats. Results indicated that sakuranetin, particularly in the sakuranetin 20 mg/kg group, led to significant reductions in systolic blood pressure (SBP) and diastolic blood pressure (DBP) by −14.53 ± 5.64% and −19.83 ± 6.56% at 4 h after administration. In the sakuranetin 50 mg/kg group, the SBP and DBP decreased by −13.27 ± 6.86% and −16.62 ± 10.01% at 2 h and by −21.61 ± 4.49% and −30.45 ± 5.21% at 4 h after administration. In addition, we identified the vasorelaxant effects of sakuranetin, attributing its mechanisms to the inhibition of calcium influx and the modulation of angiotensin II. Considering its hypotensive and vasorelaxant effects, sakuranetin could potentially serve as an antihypertensive agent. However, further research is required to evaluate the safety and long-term efficacy.https://www.mdpi.com/2227-9059/12/2/346sakuranetinnatural compoundblood pressurehypertensioncardiovascular diseasevasorelaxation
spellingShingle Sujin Shin
Junkyu Park
Ho-Young Choi
Youngmin Bu
Kyungjin Lee
Sakuranetin as a Potential Regulator of Blood Pressure in Spontaneously Hypertensive Rats by Promoting Vasorelaxation through Calcium Channel Blockade
Biomedicines
sakuranetin
natural compound
blood pressure
hypertension
cardiovascular disease
vasorelaxation
title Sakuranetin as a Potential Regulator of Blood Pressure in Spontaneously Hypertensive Rats by Promoting Vasorelaxation through Calcium Channel Blockade
title_full Sakuranetin as a Potential Regulator of Blood Pressure in Spontaneously Hypertensive Rats by Promoting Vasorelaxation through Calcium Channel Blockade
title_fullStr Sakuranetin as a Potential Regulator of Blood Pressure in Spontaneously Hypertensive Rats by Promoting Vasorelaxation through Calcium Channel Blockade
title_full_unstemmed Sakuranetin as a Potential Regulator of Blood Pressure in Spontaneously Hypertensive Rats by Promoting Vasorelaxation through Calcium Channel Blockade
title_short Sakuranetin as a Potential Regulator of Blood Pressure in Spontaneously Hypertensive Rats by Promoting Vasorelaxation through Calcium Channel Blockade
title_sort sakuranetin as a potential regulator of blood pressure in spontaneously hypertensive rats by promoting vasorelaxation through calcium channel blockade
topic sakuranetin
natural compound
blood pressure
hypertension
cardiovascular disease
vasorelaxation
url https://www.mdpi.com/2227-9059/12/2/346
work_keys_str_mv AT sujinshin sakuranetinasapotentialregulatorofbloodpressureinspontaneouslyhypertensiveratsbypromotingvasorelaxationthroughcalciumchannelblockade
AT junkyupark sakuranetinasapotentialregulatorofbloodpressureinspontaneouslyhypertensiveratsbypromotingvasorelaxationthroughcalciumchannelblockade
AT hoyoungchoi sakuranetinasapotentialregulatorofbloodpressureinspontaneouslyhypertensiveratsbypromotingvasorelaxationthroughcalciumchannelblockade
AT youngminbu sakuranetinasapotentialregulatorofbloodpressureinspontaneouslyhypertensiveratsbypromotingvasorelaxationthroughcalciumchannelblockade
AT kyungjinlee sakuranetinasapotentialregulatorofbloodpressureinspontaneouslyhypertensiveratsbypromotingvasorelaxationthroughcalciumchannelblockade